Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine

Cardiovascular Research

Volumn 110, Issue 3, 2016, Pages 408-418

  Alesutan, Ioana ^a   Feger, Martina ^a   Tuffaha, Rashad ^a   Castor, Tatsiana ^a   Musculus, Katharina ^a   Buehling, Salvatore S ^a   Heine, Christian L ^b   Kuro O, Makoto ^c   Pieske, Burkert ^b,d,h,i   Schmidt, Kurt ^b   Tomaschitz, Andreas ^b   Maerz, Winfried ^e,f,g   Pilz, Stefan ^e   Meinitzer, Andreas ^e   Voelkl, Jakob ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g SYNLAB ACADEMY   (Germany)

^h DEUTSCHES HERZZENTRUM BERLIN   (Germany)

ⁱ BERLIN INSTITUTE OF HEALTH   (Germany)

Author keywords

Homoarginine; Nitric oxide; Osteo chondrogenic signalling; Vascular calcification; Vascular smooth muscle cells

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE ISOENZYME; ARGININE; CALCIUM; CITRULLINE; COLECALCIFEROL; DETA NONOATE; HOMOARGININE; MESSENGER RNA; MOLSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PAPA NONOATE; PHOSPHATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TEMPOL; TIRON; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; BIOLOGICAL MARKER; KLOTHO PROTEIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE DEVELOPMENT; CELL TRANSFORMATION; CHONDROGENESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL CULTURE; CELL TRANSDIFFERENTIATION; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HYPERPHOSPHATEMIA; KNOCKOUT MOUSE; METABOLISM; NEPHRECTOMY; PATHOLOGY; PHENOTYPE; SMOOTH MUSCLE CELL; TIME FACTOR; VASCULAR SMOOTH MUSCLE;

ANIMALS; BIOMARKERS; CALCIUM; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CHOLECALCIFEROL; CHONDROGENESIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GLUCURONIDASE; HOMOARGININE; HUMANS; HYPERPHOSPHATEMIA; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEPHRECTOMY; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; OSTEOGENESIS; PHENOTYPE; RENAL INSUFFICIENCY; TIME FACTORS; VASCULAR CALCIFICATION;

EID: 84973312263     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvw062     Document Type: Article

References (49)

1. Atzler D, Gore MO, Ayers CR, Choe CU, Boger RH, de Lemos JA, McGuire DK, Schwedhelm E. Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study. Arterioscler Thromb Vasc Biol 2014;34:2501-2507.
2. Pilz S, Tomaschitz A, Meinitzer A, Drechsler C, Ritz E, Krane V,Wanner C, Bohm BO, Marz W. Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 2011;42:1132-1134.
3. Pilz S, Meinitzer A, Gaksch M, Grubler M, Verheyen N, Drechsler C, Hartaigh BO, Lang F, Alesutan I, Voelkl J, MarzW, Tomaschitz A. Homoarginine in the renal and cardiovascular systems. Amino Acids 2015;47:1703-1713.
4. Marz W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Bohm BO, Ritz E, Wanner C. Homoarginine, cardiovascular risk, and mortality. Circulation 2010;122:967-975.
5. Choe CU, Atzler D, Wild PS, Carter AM, Boger RH, Ojeda F, Simova O, Stockebrand M, Lackner K, Nabuurs C, Marescau B, Streichert T, Muller C, Luneburg N, De Deyn PP, Benndorf RA, Baldus S, Gerloff C, Blankenberg S, Heerschap A, Grant PJ, Magnus T, Zeller T, Isbrandt D, Schwedhelm E. Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation 2013;128:1451-1461.
6. Kayacelebi AA, Beckmann B, Gutzki FM, Jordan J, Tsikas D. GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples. Amino Acids 2014;46:2205-2217.
7. Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Doner U, Dungen HD, Tomaschitz A, Kienreich K, Gaksch M, Duvinage A, Stahrenberg R, Kunde J, Schmidt A, Marz W, Wachter R, Pieske B. Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction. J Card Fail 2014;20:923-930.
8. Pilz S, Meinitzer A, Tomaschitz A, Kienreich K, Fahrleitner-Pammer A, Drechsler C, Boehm BO, MarzW. Homoarginine deficiency is associated with increased bone turnover. Osteoporos Int 2012;23:2731-2732.
9. Ravani P, Maas R, Malberti F, Pecchini P, Mieth M, Quinn R, Tripepi G, Mallamaci F, Zoccali C. Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients. PLoS ONE 2013;8:e72694.
10. Tomaschitz A, Meinitzer A, Pilz S, Rus-Machan J, Genser B, Drechsler C, Grammer T, Krane V, Ritz E, Kleber ME, Pieske B, Kraigher-Krainer E, Fahrleitner-Pammer A, Wanner C, Boehm BO, Marz W. Homoarginine, kidney function and cardiovascular mortality risk. Nephrol Dial Transplant 2014;29:663-671.
11. Drechsler C, Kollerits B, Meinitzer A, Marz W, Ritz E, Konig P, Neyer U, Pilz S, Wanner C, Kronenberg F, Mild to Moderate Kidney Disease (MMKD) Study group. Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study. PLoS ONE 2013;8:e63560.
12. Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, Marz W, Wanner C. Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 2011;13:852-859.
13. van der Zwan LP, Davids M, Scheffer PG, Dekker JM, Stehouwer CD, Teerlink T. L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens 2013;31:1114-1123.
14. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
15. Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol 2014;307:F891-F900.
16. Speer MY, Chien YC, Quan M, Yang HY, Vali H, McKee MD, Giachelli CM. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res 2005;66:324-333.
17. Shen J, Yang M, Jiang H, Ju D, Zheng JP, Xu Z, Liao TD, Li L. Arterial injury promotes medial chondrogenesis in Sm22 knockout mice. Cardiovasc Res 2011;90:28-37.
18. Johnson JL. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. Cardiovasc Res 2014;103:452-460.
19. Lee HL, Woo KM, Ryoo HM, Baek JH. Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun 2010;391:1087-1092.
20. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005;115:1210-1220.
21. Kanno Y, Into T, Lowenstein CJ, Matsushita K. Nitric oxide regulates vascular calcification by interfering with TGF-signalling. Cardiovasc Res 2008;77:221-230.
22. Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D. Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, theirNomega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry 1998;37:10453-10460.
23. Collin P, Nefussi JR, Wetterwald A, Nicolas V, Boy-Lefevre ML, Fleisch H, Forest N. Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture. Calcif Tissue Int 1992;50:175-183.
24. Shimomura A, Matsui I, Hamano T, Ishimoto T, Katou Y, Takehana K, Inoue K, Kusunoki Y, Mori D, Nakano C, Obi Y, Fujii N, Takabatake Y, Nakano T, Tsubakihara Y, Isaka Y, Rakugi H. Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol 2014;25:1954-1965.
25. Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS, Rosenblatt KP, Kuro OM, Lang F. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 2013; 123:812-822.
26. Fischer SS, Kempe DS, Leibrock CB, Rexhepaj R, Siraskar B, Boini KM, Ackermann TF, Foller M, Hocher B, Rosenblatt KP, Kuro OM, Lang F. Hyperaldosteronism in Klothodeficient mice. Am J Physiol Renal Physiol 2010;299:F1171-F1177.
27. Morishita K, Shirai A, Kubota M, Katakura Y, Nabeshima Y, Takeshige K, Kamiya T. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr 2001;131:3182-3188.
28. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. PLoS One 2013;8:e83584.
29. Alesutan I, Musculus K, Castor T, Alzoubi K, Voelkl J, Lang F. Inhibition of phosphate-induced vascular smooth muscle cell osteo-/chondrogenic signaling and calcification by bafilomycin A1 and methylamine. Kidney Blood Press Res 2015;40:490-499.
30. Meinitzer A, Puchinger M, Winklhofer-Roob BM, Rock E, Ribalta J, Roob JM, Sundl I, Halwachs-Baumann G, Marz W. Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. Clin Chim Acta 2007;384:141-148.
31. Mayer B, Klatt P, Werner ER, Schmidt K. Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem 1995;270:655-659.
32. Kakoki M, Kim HS, Arendshorst WJ, Mattson DL. L-Arginine uptake affects nitric oxide production and blood flow in the renal medulla. Am J Physiol Regul Integr Comp Physiol 2004;287:R1478-R1485.
33. Bretscher LE, Li H, Poulos TL, Griffith OW. Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)-and N5-(iminoalkenyl)-ornithines. J Biol Chem 2003;278:46789-46797.
34. Bogle RG, Moncada S, Pearson JD, Mann GE. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol 1992;105:768-770.
35. Inoue Y, Bode BP, Beck DJ, Li AP, Bland KI, Souba WW. Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors. Ann Surg 1993; 218:350-362; discussion 362-353.
36. Buchwalow IB, Podzuweit T, BockerW, Samoilova VE, Thomas S,Wellner M, Baba HA, Robenek H, Schnekenburger J, Lerch MM. Vascular smooth muscle and nitric oxide synthase. FASEB J 2002;16:500-508.
37. El Accaoui RN, Gould ST, Hajj GP, Chu Y, Davis MK, Kraft DC, Lund DD, Brooks RM, Doshi H, Zimmerman KA, Kutschke W, Anseth KS, Heistad DD, Weiss RM. Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 2014;306:H1302-H1313.
38. Passauer J, Pistrosch F, Bussemaker E. Nitric oxide in chronic renal failure. Kidney Int 2005;67:1665-1667.
39. Wadsworth RM. Oxidative stress and the endothelium. Exp Physiol 2008;93:155-157.
40. Tsukahara H, Hiraoka M, Kobata R, Hata I, Ohshima Y, Jiang MZ, Noiri E, Mayumi M. Increased oxidative stress in rats with chronic nitric oxide depletion: measurement of urinary 8-hydroxy-2′-deoxyguanosine excretion. Redox Rep 2000;5:23-28.
41. Maranon RO, Juncos LA, Joo Turoni C, Karbiner S, Romero D, Peral de Bruno M. Tempol blunts afferent arteriolar remodeling in chronic nitric oxide-deficient hypertension without normalizing blood pressure. Clin Exp Hypertens 2014;36:132-139.
42. Wyse AT, Bavaresco CS, Hagen ME, Delwing D, Wannmacher CM, Severo Dutra-Filho C, Wajner M. In vitro stimulation of oxidative stress in cerebral cortex of rats by the guanidino compounds accumulating in hyperargininemia. Brain Res 2001;923:50-57.
43. Chae IH, ParkKW, Kim HS, Oh BH. Nitric oxide-induced apoptosis is mediated by Bax/ Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells. Clin Chim Acta 2004;341:83-91.
44. Suzuki K, Yoshimura Y, Hisada Y, Matsumoto A. Sensitivity of intestinal alkaline phosphatase to L-homoarginine and its regulation by subunit-subunit interaction. Jpn J Pharmacol 1994;64:97-102.
45. Wada H, Niwa N, Hayakawa T, Tsuge H. Changes of serum alkaline phosphatase isoenzymes in fasted rats. J Nutr Sci Vitaminol (Tokyo) 1996;42:435-447.
46. Drechsler C, Pihlstrom H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, Marz W, Holdaas H. Homoarginine and clinical outcomes in renal transplant recipients: results from the assessment of lescol in renal transplantation study. Transplantation 2015;99:1470-1476.
47. Hinterseher I, Erdman R, Elmore JR, Stahl E, Pahl MC, Derr K, Golden A, Lillvis JH, Cindric MC, Jackson K, Bowen WD, Schworer CM, Chernousov MA, Franklin DP, Gray JL, Garvin RP, Gatalica Z, Carey DJ, Tromp G, Kuivaniemi H. Novel pathways in the pathobiology of human abdominal aortic aneurysms. Pathobiology 2013;80:1-10.
48. Onar AN, Erdogan BY, Ayan I, Acar Z. Homoarginine, beta-ODAP, and asparagine contents of grass pea landraces cultivated in Turkey. Food Chem 2014;143:277-281.
49. Liu H, Li J, Zhao F,Wang H, Qu Y, Mu D. Nitric oxide synthase in hypoxic or ischemic brain injury. Rev Neurosci 2015;26:105-117.